For the Inventor, By the Inventor

Enter assignee name

Bridgewater, NJ, United States of America

Dr. Reddy's Laboratories, Incorporated

USPTO Granted Patents = 187

CIPO Patents = 8

EPO Patents = 36

Trademarks = 47

Forward Citations = 350

Loading Chart...

Loading Chart...

478 inventors (with patents filed for the assignee):

Javed Iqbal (20 out of 16 patents)

Manne Satyanarayana Reddy (18 out of 24 patents)

Ranjan Chakrabarti (17 out of 35 patents)

4. Rajeev Singh Raghuvanshi (14 out of 20 patents)

5. Pradip Kumar Sasmal (14 out of 13 patents)

6. Rajagopalan Ramanujam (14 out of 37 patents)

7. Shanavas Alikunju (13 out of 10 patents)

8. Bijay Kumar Padhi (12 out of 15 patents)

9. Ashok Tehim (12 out of 71 patents)

10. Vishweshwar Peddy (11 out of 11 patents)

11. Sateesh Kandavilli (11 out of 17 patents)

12. Venkateswarlu Akella (11 out of 15 patents)

13. Braj Bhushan Lohray (10 out of 37 patents)

14. Vidya Bhushan Lohray (10 out of 36 patents)

15. Ish Khanna (9 out of 16 patents)

187 patents: Sort by Forward Citations

1. 12433947 - Stable formulations of therapeutic antibody (2025-10-07),

2. 12428464 - Stable fusion protein formulation (2025-09-30),

3. 12030948 - Antibody formulation (2024-07-09),

4. 12024561 - Stable antibody formulation (2024-07-02),

5. 11639391 - Stable liquid pharmaceutical composition (2023-05-02),

6. 11390583 - Process for preparation of Siponimod, its salts and solid state forms thereof (2022-07-19),

7. 11382923 - Stable liquid formulations of cyclophosphamide and processes to prepare the same (2022-07-12),

8. 11364212 - Methods for treating inflammatory skin conditions (2022-06-21),

9. 11292793 - Solid dispersions of amorphous Lumateperone p-Tosylate (2022-04-05),

10. 11191740 - Methods for treating inflammatory skin conditions (2021-12-07),

11. 11168107 - Amine salt of obeticholic acid (2021-11-09),

12. 11168057 - Polymorphs and co-crystals of roxadustat (2021-11-09),

13. 11103517 - Pharmaceutical compositions for minocycline (2021-08-31),

14. 11084791 - Solid state forms of Lenvatinib Mesylate (2021-08-10),

15. 11059799 - Process for preparation of eribulin and intermediates thereof (2021-07-13),

Dr. Reddy's Laboratories is a global pharmaceutical company headquartered in India. It specializes in the development, manufacture, and marketing of generic drugs. With a presence in over 100 countries, Dr. Reddy's aims to provide affordable and innovative healthcare solutions. The company focuses on various therapeutic areas, including oncology, cardiovascular, anti-infective, and more. Dr. Reddy's Laboratories is committed to improving access to quality medicines globally.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

187 Patents

#6 in Bridgewater, NJ

#98 in New Jersey

#2,109 in US

#4,356 in the World

Bridgewater, NJ, United States of America

Dr. Reddy's Laboratories, Incorporated

Forward Citations = 350

478 inventors:

Javed Iqbal (20 out of 16 patents)

Manne Satyanarayana Reddy (18 out of 24 patents)

Ranjan Chakrabarti (17 out of 35 patents)

4. Rajeev Singh Raghuvanshi (14 out of 20 patents)

5. Pradip Kumar Sasmal (14 out of 13 patents)

Please report any incorrect information to support@idiyas.com

Loading…